(Date:11/5/2009)...HO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall/ ... supplier of innovative products for processing an... for the first quarter of fiscal 2010. ,, For t...eported revenues of $5.2 million, a 15 percent inc...uarter a year ago. The Company said the key contri...
(Date:11/5/2009)...ROOK, N.Y., Nov. 5 BioSp...pharmaceutical company developing first-in-class c...ancial results for the third quarter ended Septemb... in September of this year, the FDA,s Arthritis Ad...e of 12-0, the approval of XIAFLEX(TM) for the tre...
(Date:11/5/2009)...DIEGO, CA, November 5, 2009 /PRNewswire-FirstCall/...sed on using proprietary taste receptor-based tech...the food, beverage, and ingredient supply industri... financial results for the third quarter ended Sep...he third quarter of 2009, compared to $4.0 million...
(Date:11/5/2009)...PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-Fir... ) ("BMP Sunstone" or the "Company") today announc... 2009 financial results on,Monday, November 9, 200... will hold a conference call at 5:00 pm ET on Nove.... Listeners may access the call by,dialing 1-888-...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2...es Investors on Growth Opportunities, NEW YORK, M...ont Chairman and CEO Charles O. Holliday, Jr., sai...t innovation that addresses,global macro trends re...energy., "DuPont is a market-driven science compa...gic Decisions Conference. "The very core of our,co...
...a (Nasdaq:,PCOP), an innovator in the discovery an..., announced today that it is implementing the next... on the company,s clinical,and later-stage discove...kforce reduction of approximately 15 percent throu...as a decrease in other expenses through,improved o...
...onal Phase 2b Clinical Trial Sites in ...J., May 30 PTC Therapeutics, Inc.,(PTC) today ann...,investigational new drug for the treatment of gen...ured in a symposium at Myology 2008, the Third,Ann...eilles. The Congress,serves as the annual meeting ...
Other Biology Technology:DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy 2DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy 3Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs 2Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs 3Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs 4PTC124 Featured at Third Annual Congress of Myology 2PTC124 Featured at Third Annual Congress of Myology 3PTC124 Featured at Third Annual Congress of Myology 4(Date:11/4/2009)...PRNewswire/ -- GenVault Corporation, the leader in...mic discovery, medicine and identification, today ...sident and CEO, will be presenting at the BIOCOM I...d 27th in La Jolla, CA. ,, During the presentat...mpany together with recent customer, technical and...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
(Date:11/3/2009)...mate loner of the ocean, cruising thousands of mil...as discovered that the sharks have maintained such...of thousands of years the white sharks in the nort...nto a population genetically distinct from sharks ...rge, highly mobile species," said Salvador Jorgens...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3 0 Electronic Data Capture Software 14464 1Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3 0 Electronic Data Capture Software 14464 2Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3 0 Electronic Data Capture Software 14464 3Sinus Buster Paves the Way for Natural OTC Products and Mainstream Success 59428 1Sinus Buster Paves the Way for Natural OTC Products and Mainstream Success 59428 2Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 1Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 2Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 3Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 4Cleanascite HC 16000 from Biotech Support Group
...izer is a bovine protein-free alternative to Stabi...lution that contains non-toxic chemicals in a PBS ...and does not contain a preservative. This product...omolecules that are absorbed or immobilized to sol...
ELLMAN'S REAGENT from Pierce Biotechnology, Inc.
...Gradient thermal cycler which enables you to optim...Wide linear gradient - The most linear gradient cy...Protocols can be optimised in a single experiment....tes a large, 115 x 90mm, touch-sensitive screen,th...
Biology Products: